30 / 8 / 2016 Midnight
Immunisation is one of the most successful and cost-effective public health interventions and a cornerstone of public health. High immunisation rates are key to preventing the spread of infectious disease, complications and possible early death among individuals. It protects the population’s health through both individual and herd immunity.
Following recommendations from the Joint Committee on Vaccinations and Immunisations (JCVI), a number of programmes are commissioned for delivery by general practice. This includes those which are legally directed by the Secretary of State for Health to establish or offer, and those NHS England has prescribed. Some enhanced services (ES) delivered by GMS practices have payments directed in the statement of financial entitlements (SFE). The full set of enhanced services can be found on the NHS England enhanced services webpage.
A number of changes have been agreed to the vaccination and immunisation programmes:
The following programmes continue unchanged:
- The item of service fee has been uplifted to £9.80.
- Vaccination of babies against menB will continue but paracetamol will no longer be centrally supplied and there will be no new catch-up (babies eligible under the catch-up element of the programme in 2015/16 remain eligible for their booster dose in 2016/17).
- The infant dose of menC will be removed from the routine childhood schedule following on from advice from JCVI. Due to the two year payment lag, the funding will be removed from April 2018. All other vaccines as part of the targeted programme remain unchanged.
- The menACWY 18 years on 31 August vaccination will be expanded to allow for the vaccination of people aged 19 – 25 year to be vaccinated on an opportunistic basis should the self-present and request vaccination. The cohort has also been expanded to allow for the vaccination of 19-25 year old non-freshers.
- Pertussis – the expansion of the programme to allow the vaccination of pregnant women from 20 weeks in to the pregnancy.
- childhood seasonal influenza
- HPV for adolescent girls
- hepatitis B (newborn babies)
- measles mumps and rubella (aged 16 and over)
- meningococcal ACWY freshers
- meningococcal booster
The detail of these programmes are available in the vaccination and immunisation programmes 2016/17 guidance.
A set of FAQs were developed to support commissioners in delivery of the 16/17 GMS contract, they can be found on our FAQs page